Welcome
SEC Pharma work with pharmaceutical, CRO and biotech organisations throughout Europe focusing on recruitment in Clinical Research, Biometrics, Pharmacovigilance, Regulatory Affairs, Medical Affairs, Sales, Marketing and Medical Communications.
We know that many critical business functions within the global pharmaceutical industry continue to face the challenge of finding people with the right skills, experience and attitude. Key positions can, critically, be left unfulfilled for months, placing pressure on existing teams with wider implications for business success and profitability.
SEC Pharma has the ability to find, recruit and retain the industry’s best people. We firmly believe that proactively sourcing top talent and marketing the benefits of joining your organisation effectively is essential to ensure you attract the right people ahead of the competition, and in turn our candidates secure the role that is right for them.
Established in 1995, SEC Pharma consists of a team of European, multi-lingual and highly experienced consultants who each have a background in clinical or scientific disciplines and know their markets extremely well. Our consultants work from two shared hub offices in London and Woking in the UK, however each one has a focus on a particular skill set and specific geography, depending on their technical knowledge, cultural awareness and language skills.
SEC latest news
-
SEC Pharma attend 2012 ICR Conference in London 14-15 MayMay 9, 2012 - SEC Pharma will be attending the ICR 2012 Annual Conference: Clinical Research sans Frontieres, which is being held at the Grand Connaught Rooms in Central London on 14th & 15th May. Our representative this year is Leslie Reeves, a specialist in recruiting within the Clinical Research sector . If you would like to arrange a
read more... -
M3 Europe and SEC Pharma are mergingMarch 9, 2012 - Two of Europe’s leading pharmaceutical recruitment suppliers are uniting to become one of the largest specialist companies in the sector. Previously both companies, owned by RDL Corporation, operated independently but as from 12th March 2012, M3 Europe and SEC Pharma will be united under the SEC Pharma brand and under one management team. The merger
read more...
Social media updates
English
Español
Deutsch
Français